Insights: Publications COVID-19-Related Delays in Filing Patent and Trademark Documents
Please note: The below information may require updating, including additional clarification, as the COVID-19 pandemic continues to develop. Please monitor our main COVID-19 Task Force page and/or your email for updates.
The European Patent Office (EPO), the European Union Intellectual Property Office (EUIPO) and the United State Patent and Trademark Office (USPTO) have each announced some relaxation of certain rules and procedures to accommodate 2019 novel coronavirus (COVID-19)-related delays and interruptions in filings.
The EPO will extend all deadlines accruing after March 15, 2020 until April 17, 2020, including deadlines for international applications under the PCT. The currently extended deadline of April 17 may be further extended by a future Notice.
However, to take advantage of the EPO deadline extensions, applicants or their representatives must offer "evidence that on any of the ten days preceding the day of expiry of a period, it was not possible to observe the time limit due to” a COVID-19 related disruption.
To obtain an extension of a PCT deadline, the interested party must offer “satisfactory evidence that a time limit under the PCT was not met due to natural calamity or other like reason [i.e., a delay caused by the COVID-19 outbreak] in the locality where the interested party resides.” The full EPO Notice is available here.
The EUIPO extensions appear to be more generous. Trademark filings in the EU office with time limits expiring between March 9, 2020 and April 30, 2020 are currently being extended to May 1, 2020. The EUIPO Decision can be found here.
The USPTO will waive the petition fee normally required with any petition to revive an abandoned application or the termination or limitation of a reexamination proceeding. The USPTO Notice is here. A copy of the USPTO Notice that accompanies a petition (e.g., to revive), will be treated as a representation that the relevant delay in filing “was because the practitioner, applicant or at least one inventor was personally affected by the Coronavirus outbreak such that they were unable to timely reply." As with any representation of the Patent Office, the applicant, practitioner, or inventor would be well-advised to maintain evidence supporting the representation.
According to the same USPTO Notice, Trademark petition fees will also be waived, at least under certain circumstance. Petitions to revive an abandoned application or reinstate a cancelled or expired registration “must include a statement explaining how the failure to respond to the Office communication was due to the effects of the Coronavirus outbreak.”
The USPTO Notice expressly does NOT grant any waivers or extension or deadlines set by statute, such as the deadline for non-provisional patent applications that claim priority to a foreign priority application, a provisional patent application, or a previously filed parent patent application, or the three-month deadline to pay an issue fee, among others.
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.